{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:24:19Z","timestamp":1772119459086,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10147-023-02392-0","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:02:00Z","timestamp":1692144120000},"page":"1421-1430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Retrospective study of the efficacy and safety of docetaxel\/carboplatin combination therapy as postoperative adjuvant chemotherapy for nonsquamous cell carcinoma of the cervix"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4565-2360","authenticated-orcid":false,"given":"Ryo","family":"Koike","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7354-6977","authenticated-orcid":false,"given":"Mayu","family":"Yunokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4897-5029","authenticated-orcid":false,"given":"Kohei","family":"Omatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6888-4358","authenticated-orcid":false,"given":"Nozomi","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2742-5282","authenticated-orcid":false,"given":"Hidetaka","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1372-6145","authenticated-orcid":false,"given":"Hiroyuki","family":"Kanao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2249-1333","authenticated-orcid":false,"given":"Akihiko","family":"Sekizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"key":"2392_CR1","unstructured":"National Cancer Center (2022) Title of subordinate document. In: Cancer type statistics: cervix. National Cancer Center. Available via DIALOG. https:\/\/ganjoho.jp\/reg_stat\/statistics\/stat\/cancer\/17_cervix_uteri.html. Accessed Jan 2023"},{"key":"2392_CR2","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1002\/cncr.33795","volume":"127","author":"S Lin","year":"2021","unstructured":"Lin S, Gao K, Gu S et al (2021) Worldwide cervical cancer incidence and mortality trends, with predictions for the next 15 years. Cancer 127:4030\u20134039","journal-title":"Cancer"},{"key":"2392_CR3","first-page":"796","volume":"73","author":"Japanese Society of Obstetrics and Gynecology","year":"2019","unstructured":"Japanese Society of Obstetrics and Gynecology (2019) Patient annual report. J Jpn Soc Obstet Gynecol 73:796\u2013813","journal-title":"J Jpn Soc Obstet Gynecol"},{"key":"2392_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ygyno.2012.06.021","volume":"127","author":"S Mabuchi","year":"2012","unstructured":"Mabuchi S, Okazawa M, Matsuo K et al (2012) Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma. Gynecol Oncol 127:114\u2013120","journal-title":"Gynecol Oncol"},{"key":"2392_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ygyno.2012.01.034","volume":"125","author":"K Katanyoo","year":"2012","unstructured":"Katanyoo K, Sanguanrungsirikul S, Manusirivithaya S (2012) Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer. Gynecol Oncol 125:292\u2013296","journal-title":"Gynecol Oncol"},{"key":"2392_CR6","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2017.28.e32","volume":"28","author":"W Yamagami","year":"2017","unstructured":"Yamagami W, Nagase S, Takahashi F et al (2017) Clinical statistics of gynecologic cancers in Japan. J Gynecol Oncol 28:e32","journal-title":"J Gynecol Oncol"},{"key":"2392_CR7","first-page":"1304","volume-title":"Berek & Novak\u2019s Gynecology","author":"C Miller","year":"2012","unstructured":"Miller C, Elkas JC (2012) Cervical and vaginal cancer. In: Berek JS (ed) Berek & Novak\u2019s Gynecology, 15th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1304\u20131349","edition":"15"},{"key":"2392_CR8","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2016.27.e29","volume":"27","author":"Y Ikeda","year":"2016","unstructured":"Ikeda Y, Furusawa A, Kitagawa R et al (2016) Practice patterns of adjuvant therapy for intermediate\/high recurrence risk cervical cancer patients in Japan. J Gynecol Oncol 27:e29","journal-title":"J Gynecol Oncol"},{"key":"2392_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-018-1351-y","volume":"24","author":"Y Ebina","year":"2019","unstructured":"Ebina Y, Mikami M, Nagase S et al (2019) Japanese society of gynecologic oncology guidelines 2017 for the treatment of uterine cervical cancer. Int J Clin Oncol 24:1\u201319","journal-title":"Int J Clin Oncol"},{"key":"2392_CR10","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1447-0756.2008.00739.x","volume":"34","author":"M Hosaka","year":"2008","unstructured":"Hosaka M, Watari H, Takeda M et al (2008) Treatment of cervical cancer with adjuvant chemotherapy versus adjuvant radiotherapy after radical hysterectomy and systematic lymphadenectomy. J Obstet Gynaecol Res 34:552\u2013556","journal-title":"J Obstet Gynaecol Res"},{"key":"2392_CR11","first-page":"425","volume":"34","author":"M Shimada","year":"2013","unstructured":"Shimada M, Nishimura R, Hatae M et al (2013) Comparison of adjuvant chemotherapy and radiotherapy in patients with cervical adenocarcinoma of the uterus after radical hysterectomy: SGSG\/TGCU Intergroup surveillance. Eur J Gynaecol Oncol 34:425\u2013428","journal-title":"Eur J Gynaecol Oncol"},{"key":"2392_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/IGC.0000000000000650","volume":"26","author":"S Sato","year":"2016","unstructured":"Sato S, Shimada M, Ohta T et al (2016) Feasibility study of adjuvant chemotherapy using taxane plus carboplatin for high-risk patients with uterine cervical non-squamous cell carcinoma after radical hysterectomy. Int J Gynecol Cancer 26:561\u2013567","journal-title":"Int J Gynecol Cancer"},{"key":"2392_CR13","first-page":"265","volume":"44","author":"MS Piver","year":"1974","unstructured":"Piver MS, Rutledge F, Smith JP (1974) Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44:265\u2013272","journal-title":"Obstet Gynecol"},{"key":"2392_CR14","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2019.30.e71","volume":"30","author":"H Kanao","year":"2019","unstructured":"Kanao H, Matsuo K, Aoki Y et al (2019) Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer. J Gynecol Oncol 30:e71","journal-title":"J Gynecol Oncol"},{"key":"2392_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48:452\u2013458","journal-title":"Bone Marrow Transplant"},{"key":"2392_CR16","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","volume":"18","author":"WA Peters 3rd","year":"2000","unstructured":"Peters WA 3rd, Liu PY, Barrett RJ 2nd et al (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18:1606\u20131613","journal-title":"J Clin Oncol"},{"key":"2392_CR17","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1097\/IGC.0b013e3182647265","volume":"22","author":"T Toita","year":"2012","unstructured":"Toita T, Kitagawa R, Hamano T et al (2012) Feasibility and acute toxicity of concurrent chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg\/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a multi-institutional phase 2 study (JGOG1066). Int J Gynecol Cancer 22:1420\u20131426","journal-title":"Int J Gynecol Cancer"},{"key":"2392_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/cncr.20734","volume":"103","author":"T Nakano","year":"2005","unstructured":"Nakano T, Kato S, Ohno T et al (2005) Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix. Cancer 103:92\u2013101","journal-title":"Cancer"},{"key":"2392_CR19","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ijrobp.2007.04.028","volume":"69","author":"T Ohno","year":"2007","unstructured":"Ohno T, Kato S, Sato S et al (2007) Long-term survival and risk of second cancers after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 69:740\u2013745","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2392_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ygyno.2006.03.050","volume":"102","author":"I Vistad","year":"2006","unstructured":"Vistad I, Foss\u00e5 DS, Dahl AA (2006) A critical review of the patient-rated quality of life studies of long-term survivors of cervical cancer. Gynecol Oncol 102:563\u2013572","journal-title":"Gynecol Oncol"},{"key":"2392_CR21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/pon.1426","volume":"18","author":"ER Greimel","year":"2009","unstructured":"Greimel ER, Winter R, Kapp KS et al (2009) Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study. Psychooncology 18:476\u2013482","journal-title":"Psychooncology"},{"key":"2392_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0167-8140(03)00197-X","volume":"68","author":"JM Kirwan","year":"2003","unstructured":"Kirwan JM, Symonds P, Green JA et al (2003) A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 68:217\u2013226","journal-title":"Radiother Oncol"},{"key":"2392_CR23","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1097\/AOG.0000000000003280","volume":"133","author":"M Matsuo","year":"2019","unstructured":"Matsuo M, Shimada M, Yamaguchi S et al (2019) Association of radical hysterectomy surgical volume and survival for early-stage cervical cancer. Obstet Gynecol 133:1086\u20131098","journal-title":"Obstet Gynecol"},{"key":"2392_CR24","unstructured":"Radiation Therapy Oncology Group (2022) Title of subordinate document. In: Chemotherapy and pelvic radiation therapy with or without additional chemotherapy in treating patients with high-risk early-stage cervical cancer after radical hysterectomy. National Library of Medicine. Available via DIALOG. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00980954. Accessed Jan 2023"},{"key":"2392_CR25","unstructured":"Furusawa A (2023) Title of subordinate document. In: Adjuvant Chemotherapy Versus Radiotherapy For Postoperative Cervical Cancer; a phase 3 trial (AFTER trial). Japan Registry of Clinical Trials. Available via DIALOG. https:\/\/jrct.niph.go.jp\/en-latest-detail\/jRCTs041190042. Accessed Jan 2023"},{"key":"2392_CR26","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ygyno.2014.01.043","volume":"132","author":"JM Noh","year":"2014","unstructured":"Noh JM, Park W, Kim YS et al (2014) Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13\u201310). Gynecol Oncol 132:618\u2013623","journal-title":"Gynecol Oncol"},{"key":"2392_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ygyno.2018.04.009","volume":"149","author":"M Matoda","year":"2018","unstructured":"Matoda M, Takeshima N, Michimae H et al (2018) Postoperative chemotherapy for node-positive cervical cancer: results of a multicenter phase II trial (JGOG1067). Gynecol Oncol 149:513\u2013519","journal-title":"Gynecol Oncol"},{"key":"2392_CR28","first-page":"1563","volume":"20","author":"S Takekida","year":"2010","unstructured":"Takekida S, Fujiwara K, Nagao S et al (2010) Phase II study of combination chemotherapy with docetaxel and carboplatin for locally advanced or recurrent cervical cancer. Int J Gynecol Cancer 20:1563\u20131568","journal-title":"Int J Gynecol Cancer"},{"key":"2392_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1006\/gyno.1999.5387","volume":"73","author":"A Sedlis","year":"1999","unstructured":"Sedlis A, Bundy BN, Rotman MZ et al (1999) A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study. Gynecol Oncol 73:177\u2013183","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02392-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-023-02392-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02392-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:08:06Z","timestamp":1695946086000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-023-02392-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["2392"],"URL":"https:\/\/doi.org\/10.1007\/s10147-023-02392-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2849912\/v1","asserted-by":"object"}]},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,16]]},"assertion":[{"value":"23 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No author has any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}